Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.

Co-located with our

REAL WORLD EVIDENCE SUMMIT

The medical market is becoming more complex, yet HCPs can easily determine the performance of medicines from an increasing range of online sources. So, pharma companies must work harder to create and communicate the unique value of their medicines if they are to operate a credible, profitable commercial model. The key is to truly understand customer needs on a deeper level, and then combine innovative solutions with skilled teams to ensure that your brand truly resonates with what the market requires. eyeforpharma Japan 2018's Commercial Excellence summit has covered a range of topics to elevate Japan's pharma to the next level.

Topics discussed in 2018:

  • Do you really know your customer?
    Gain a deeper market understanding to predict customer behavior and determine where to add value
  • Create a comprehensive database
    Make better decisions and open more doors with more reliable customer data
  • Enhance customer engagement through digital innovation
    Determine which technologies will get you ahead
  • From mass-market to targeted
    Improve conversion rate with a more sophisticated approach
  • Introduce smarter thinking into your sales force
    Go beyond simple sales techniques so that MRs become the customer representatives of the future

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

The unrivalled speaker line-up for 2018

Stefan Woxström
Stefan Woxström

AstraZeneca K.K.

Representative Director and President

Thorsten Poehl
Thorsten Poehl

Boehringer Ingelheim Japan, Inc

President and Representative Director of BIJI // Chairman and Representative Director of NBI, BIVJ, and BIS

Ole Mølskov Bech
Ole Mølskov Bech

Novo Nordisk Pharma Ltd.

President and Representative Director

Satoru Noguchi
Satoru Noguchi

Celgene K.K.

President

Masako Nakamura
Masako Nakamura

Aegerion Pharmaceuticals K.K.

President, Representative Director

Koji Fujimoto
Koji Fujimoto

Councillor, Cabinet Secretariat, Government of Japan

Deputy Director-General, Office of Healthcare Policy

Miki Satoshi
Miki Satoshi

UCB Japan Co., Ltd.

Japan Representative Director, Vice President, Head of CoE Strategy & Planning for East Asia Region

David Lennon
David Lennon

Novartis

Oncology General Manager Japan

Why attend eyeforpharma Japan?

Collaborate:

Establish better relationships with key industry leaders and innovators

Network:

400+ colleagues, comprehensive exhibition area and drink receptions

Learn:

20+ expert speakers, industry-driven agenda, panel discussion and workshops

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription